Texas A&M University-Kingsville (TAMUK) is a regional university with a mission of providing quality education to its students. Over 68 percent of the students are minority many of whom are academically and economically disadvantaged. The mission of the NIH/RIMI program at TAMUK is to enhance the research infrastructure and expand research capabilities to promote collaborative research with doctoral granting institutions which have a well funded program. The objectives of the NIH/RIMI are to: (1) improve the research infrastructure by adding more faculty with biomedical research training; (2) establish collaborative research projects with doctoral-granting institutions; (3) establish a core research facility with technical support; and (4) establish a Ph.D. pipeline for disadvantaged students. The NIH/RIMI goals are consistent with the goals found in the biology Strategic Plan which were designed to enhance the research infrastructure in the Department of Biology by adding new faculty and thereby improving the quality and quantity of biomedical research. The core research facility with technical support and adequate Internet facilities are essential in attracting quality research faculty who will be collaborating with faculty at other universities. The venom research program, which has been traditionally strong, will be strengthened through collaboration with faculty at doctoral-granting universities. The participating universities have agreed to assist in the expansion of the venom research program. In addition, three new faculty positions will be added, two in biology and one in chemistry. The new faculty hired in the NIH/RIMI program at TAMUK will be linked with research projects at the participating universities. The faculty will be provided with start-up money, laboratory space, and reduced teaching assignments of six hours. The University will provide financial support for graduate research assistants in the RIMI program. Students completing a Master's program at TAMUK will be accepted into a Ph.D. program with financial support from a Ph.D. granting university. The Ph.D. pipeline will be most beneficial to those students who need an additional two years of academic training before entering a Ph.D. program. The NIH/RIMI program will expand the biomedical research opportunities for faculty and students. Faculty will develop quality biomedical research programs which will compete at the national level for funding. Students will be accepted into nationally ranked Ph.D. programs. The NIH/RIMI program at TAMUK is designed to attract and support quality research faculty in developing strong research projects which will be institutionalized.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Exploratory Grants (P20)
Project #
5P20RR011594-05
Application #
6078286
Study Section
Special Emphasis Panel (ZRR1-RIMI-4 (02))
Program Officer
Mcnairy, Sidney A
Project Start
1995-09-30
Project End
2001-09-29
Budget Start
1999-09-30
Budget End
2000-09-29
Support Year
5
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Texas A&M University-Kingsville
Department
Biology
Type
Schools of Arts and Sciences
DUNS #
City
Kingsville
State
TX
Country
United States
Zip Code
78363
Salazar, Ana Maria; Guerrero, Belsy; Cantu, Bruno et al. (2009) Venom variation in hemostasis of the southern Pacific rattlesnake (Crotalus oreganus helleri): isolation of hellerase. Comp Biochem Physiol C Toxicol Pharmacol 149:307-16
Galan, Jacob A; Sanchez, Elda E; Rodriguez-Acosta, Alexis et al. (2004) Neutralization of venoms from two Southern Pacific Rattlesnakes (Crotalus helleri) with commercial antivenoms and endothermic animal sera. Toxicon 43:791-9
Sanchez, Elda E; Ramirez, Maria Susana; Galan, Jacob A et al. (2003) Cross reactivity of three antivenoms against North American snake venoms. Toxicon 41:315-20
Sanchez, Elda E; Galan, Jacob A; Perez, John C et al. (2003) The efficacy of two antivenoms against the venom of North American snakes. Toxicon 41:357-65
McKeller, Morgan R; Perez, John C (2002) The effects of Western Diamondback Rattlesnake (Crotalus atrox) venom on the production of antihemorrhagins and/or antibodies in the Virginia opossum (Didelphis virginiana). Toxicon 40:427-39
Perez, J C; McKeller, M R; Perez, J C et al. (2001) An internet database of crotaline venom found in the United States. Toxicon 39:621-32
Sanchez, E E; Soliz, L A; Ramirez, M S et al. (2001) Partial characterization of a basic protein from Crotalus molossus molossus (northern blacktail rattlesnake) venom and production of a monoclonal antibody. Toxicon 39:523-37
Martinez, R R; Perez, J C; Sanchez, E E et al. (1999) The antihemorrhagic factor of the Mexican ground squirrel, (Spermophilus mexicanus). Toxicon 37:949-54
Ramirez, M S; Sanchez, E E; Garcia-Prieto, C et al. (1999) Screening for fibrinolytic activity in eight Viperid venoms. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol 124:91-8
Perez, J C; Sanchez, E E (1999) Natural protease inhibitors to hemorrhagins in snake venoms and their potential use in medicine. Toxicon 37:703-28

Showing the most recent 10 out of 11 publications